March 24, 2021

TB Alliance Welcomes Drug-Resistant TB Survivors to Access Advisory Committee

Dr. Zolelwa Sifumba and Dr. Saurabh Rane to Help Increase Access to Urgently Needed Improved TB Treatments
March 24, 2021

Amid Global Pandemic, TB Treatment Innovation Advances at an Unprecedented Pace

Presentation at CROI highlights the durability and response to new treatment for highly drug-resistant tuberculosis.
March 23, 2021

TB Alliance Issues Call for Researchers to Access TB Biomarker Repository

Researchers Invited to Access MARK-TB Library of Samples from Clinical Trials
March 18, 2021

TB Alliance and GSK announce partnership to develop new TB therapeutics

Partnership between pharmaceutical firm and non-profit product development partnership seeks to identify and advance new compounds to achieve breakthroughs in TB treatment
February 1, 2021

ZebiAI and TB Alliance Announce Collaboration to Apply ML-Driven Discovery Platform to Tuberculosis Targets

TB Alliance to leverage ZebiAI’s platform to discover novel probe compounds for important tuberculosis targets, with options for drug discovery
January 28, 2021

New Report Reveals that R&D Partnerships Serving Neglected Communities have Produced Dozens of Life-Saving Innovations Since 2010

Novel approach for minimizing investment risks and stretching limited budgets has 375 innovations targeting infectious diseases under development
December 14, 2020

TB Alliance Announces First Patient Dosed with TBAJ-587 in Phase 1 Study

Study seeks to further develop a new compound to treat patients with tuberculosis